UMB Bank’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.54K Hold
35
﹤0.01% 2078
2026
Q1
$4.47K Buy
+35
New +$4.37K ﹤0.01% 2059
2023
Q4
Sell
-3,591
Closed -$262K 1763
2023
Q3
$262K Sell
3,591
-550
-13% -$43.9K ﹤0.01% 507
2023
Q2
$345K Sell
4,141
-229
-5% -$19.2K 0.01% 470
2023
Q1
$333K Sell
4,370
-500
-10% -$41.5K 0.01% 469
2022
Q4
$404K Sell
4,870
-7,135
-59% -$578K 0.01% 452
2022
Q3
$952K Buy
12,005
+6,536
+120% +$551K 0.02% 349
2022
Q2
$406K Sell
5,469
-6,218
-53% -$467K 0.01% 502
2022
Q1
$1.05M Sell
11,687
-201
-2% -$18.6K 0.01% 381
2021
Q4
$1.33M Buy
+11,888
New +$1.43M 0.02% 358

Other funds holding XBI

UMB Bank's XBI Position: Q2 2026 in Review

UMB Bank held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 35 shares worth $5.54K. The position accounts for ﹤0.01% of the portfolio, ranked #2078.

UMB Bank first reported a position in XBI in Q4 2021 and has held it in 10 quarters since. The position peaked at $1.33M in Q4 2021. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • UMB Bank held 35 shares of State Street SPDR S&P Biotech ETF worth $5.54K as of Q2 2026.
  • UMB Bank left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
  • State Street SPDR S&P Biotech ETF made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #2078 holding.
  • UMB Bank first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and has held it in 10 quarters since.
  • UMB Bank's State Street SPDR S&P Biotech ETF position peaked at $1.33M in Q4 2021.
  • 932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.